This CTD dossier owner and manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

This CTD dossier owner and manufacturer, established in 2004, is a leader in research and development of prescription medications adhering to European quality standards. Focusing on affordability, they utilize around 80 active ingredients to produce drugs across four key therapy areas: cardiovascular, nervous system, diabetes, and dyslipidemia. Their R&D department, equipped with German technology and staffed by specialists, has successfully developed prolonged-release and micronized dosage forms.They primarily operate in Vietnam but also export to Cambodia, Indonesia, Singapore, and other regions.

This CTD dossier owner and manufacturer, founded in 2003 and operational since 2008, is dedicated to providing advanced pharmaceutical products across various therapeutic areas. The manufacturing facility adheres to WHO-GMP norms and international regulatory standards, specializing in tablets, capsules, and oral liquids. The company leverages state-of-the-art machinery and modern building designs within a strategically located production site accessible by road and rail. Products are distributed both domestically and internationally through a parent group that focuses on sales and promotion.